| scholarly article | Q13442814 |
| P2093 | author name string | Emanuella de Aragão Tavares | |
| Renata C Leitão | |||
| Aurigena A de Araújo | |||
| Caroline A C X de Medeiros | |||
| Gerlane C B Guerra | |||
| Gerly A de Castro Brito | |||
| Maisie M Barbosa | |||
| Raimundo F de Araújo Júnior | |||
| Roseane C Vasconcelos | |||
| Susana B Ribeiro | |||
| Vinícius B Garcia | |||
| P2860 | cites work | S-nitrosoglutathione accelerates recovery from 5-fluorouracil-induced oral mucositis | Q27324192 |
| TGFbeta in Cancer | Q28288866 | ||
| The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on | Q28296342 | ||
| Angiotensin II differentially regulates interleukin-1-beta-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK | Q28582091 | ||
| An improvement of the 2ˆ(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis | Q30882732 | ||
| Effects of low-level laser therapy on collagen expression and neutrophil infiltrate in 5-fluorouracil-induced oral mucositis in hamsters. | Q33641739 | ||
| Radiation-Induced Oral Mucositis | Q33711362 | ||
| Oral complications of cancer therapy | Q34729161 | ||
| Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review | Q35125688 | ||
| The role of Smad7 in oral mucositis | Q35143104 | ||
| Azilsartan reduced TNF-α and IL-1β levels, increased IL-10 levels and upregulated VEGF, FGF, KGF, and TGF-α in an oral mucositis model | Q35562699 | ||
| The pathobiology of mucositis | Q35730297 | ||
| Attenuation of Immune-Mediated Renal Injury by Telmisartan, an Angiotensin Receptor Blocker and a Selective PPAR-γ Activator | Q35791764 | ||
| Carvedilol Improves Inflammatory Response, Oxidative Stress and Fibrosis in the Alcohol-Induced Liver Injury in Rats by Regulating Kuppfer Cells and Hepatic Stellate Cells | Q35927446 | ||
| Management of oral mucositis in patients who have cancer | Q36494114 | ||
| The renin angiotensin aldosterone system and insulin resistance in humans | Q36550987 | ||
| Pathobiology of oral mucositis: novel insights and opportunities. | Q37019001 | ||
| Positive and negative signaling components involved in TNFalpha-induced NF-kappaB activation | Q37028019 | ||
| Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis. | Q51113894 | ||
| Olmesartan Prevented Intra-articular Inflammation Induced by Zymosan in Rats. | Q51350200 | ||
| The effect of the angiotensin II receptor, type 1 receptor antagonists, losartan and telmisartan, on thioacetamide-induced liver fibrosis in rats. | Q51364426 | ||
| Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis. | Q51772543 | ||
| Glutamine and alanyl-glutamine accelerate the recovery from 5-fluorouracil-induced experimental oral mucositis in hamster. | Q51798290 | ||
| Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hamster. | Q51804363 | ||
| Angiotensin type 1 receptor antagonists induce human in-vitro adipogenesis through peroxisome proliferator-activated receptor-γ activation | Q56982054 | ||
| Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation | Q57450697 | ||
| An animal model for mucositis induced by cancer chemotherapy | Q68754180 | ||
| Utilization of the biotin/avidin system to amplify the sensitivity of the enzyme-linked immunosorbent assay (ELISA) | Q71689200 | ||
| Requirement for STAT1 in LPS-induced gene expression in macrophages | Q73778456 | ||
| Defining mechanisms of action of interleukin-11 on the progression of radiation-induced oral mucositis in hamsters | Q74015493 | ||
| Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B | Q74139535 | ||
| Prospective evaluation of oral mucositis in acute leukemia patients receiving chemotherapy | Q84349532 | ||
| Telmisartan decreases inflammation by modulating TNF-α, IL-10, and RANK/RANKL in a rat model of ulcerative colitis | Q87229466 | ||
| Telmisartan inhibits the proinflammatory effects of homocysteine on human endothelial cells through activation of the peroxisome proliferator-activated receptor-δ pathway | Q88216217 | ||
| Telmisartan, an AT1 receptor blocker and a PPAR gamma activator, alleviates liver fibrosis induced experimentally by Schistosoma mansoni infection | Q37071406 | ||
| The regulation of matrix metalloproteinases and their inhibitors. | Q37079430 | ||
| Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis | Q37192194 | ||
| Mucositis: The impact, biology and therapeutic opportunities of oral mucositis | Q37614665 | ||
| Targeted inhibition of IL-18 attenuates irinotecan-induced intestinal mucositis in mice. | Q37719409 | ||
| Telmisartan: a review of its pharmacodynamic and pharmacokinetic properties | Q37761376 | ||
| Mucositis in malignant hematology | Q37810071 | ||
| Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis | Q37896399 | ||
| Telmisartan for the reduction of cardiovascular morbidity and mortality | Q37960631 | ||
| Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. | Q38044278 | ||
| Systematic review of basic oral care for the management of oral mucositis in cancer patients | Q38135744 | ||
| Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy: demonstration of increased frequency, severity, resistance to palliation, and impact on quality of life | Q39312586 | ||
| Effect of telmisartan on levels of IL-1, TNF-α, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model | Q42070379 | ||
| NF-kappaB-dependent production of nitric oxide by astrocytes mediates apoptosis in differentiated PC12 neurons following exposure to manganese and cytokines | Q42484079 | ||
| TLR4/MyD88/NF-κB signaling and PPAR-γ within the paraventricular nucleus are involved in the effects of telmisartan in hypertension | Q42696095 | ||
| Effect of oral mucosal adhesive films containing ginsenoside Rb1 on 5-fluorouracil-induced oral mucositis in hamsters. | Q45956528 | ||
| Inhibition of IL-10-induced STAT3 activation by 15-deoxy-Delta12,14-prostaglandin J2. | Q46445868 | ||
| Chronic intermittent hypoxia-induced neuronal apoptosis in the hippocampus is attenuated by telmisartan through suppression of iNOS/NO and inhibition of lipid peroxidation and inflammatory responses | Q46804610 | ||
| Protective effect of dexamethasone on 5-FU-induced oral mucositis in hamsters | Q47616328 | ||
| Chemotherapy induced oral mucositis: prevention is possible | Q47788753 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | fluorouracil | Q238512 |
| oral mucositis | Q68879193 | ||
| P304 | page(s) | 1204 | |
| P577 | publication date | 2018-01-01 | |
| P1433 | published in | Frontiers in Physiology | Q2434141 |
| P1476 | title | Telmisartan Modulates the Oral Mucositis Induced by 5-Fluorouracil in Hamsters | |
| P478 | volume | 9 |
Search more.